Cann American Corp (CNNA)

[MU_Redskin1]

Prodigy acquisition 8K

https://www.sec.gov/ix?doc=/Archives/edgar/data/1368620/000168316823001536/cann_8k.htm

Item 1.01 Entry into a Material Definitive Agreement.

On January 30, 2023, the Company entered into a Binding Letter of Intent to acquire Prodigy Stem Cell, LLC as a wholly owned subsidiary of the Company.

Item 2.01 Completion of Acquisition or Disposition of Assets.

On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell, LLC as a wholly owned subsidiary. Prodigy Stem Cell, LLC is a New Jersey based company focused on sales, marketing, and consulting for regenerative medicines.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 1, 2023, the Company appointed Peter Caruso as a Director of the Company. Mr. Caruso has over 20 years of business development experience and is the Founder of Prodigy Stem Cell, LLC.

GLTA CNNA!

Cheers, Red